FALLOPIAN TUBE CLEAR CELL ADENOCARCINOMA
Clinical trials for FALLOPIAN TUBE CLEAR CELL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new FALLOPIAN TUBE CLEAR CELL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for FALLOPIAN TUBE CLEAR CELL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Ovarian cancer vaccine shows promise in early safety trial
⭐️ VACCINE ⭐️ CompletedThis early-phase study tested a personalized vaccine made from patients' own white blood cells to treat advanced ovarian, fallopian tube, or primary peritoneal cancer. The vaccine was designed to help the immune system recognize and attack cancer cells. The main goal was to check…
Matched conditions: FALLOPIAN TUBE CLEAR CELL ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 14:03 UTC
-
Major trial tests best route for ovarian cancer treatment
Disease control CompletedThis study tested whether giving chemotherapy directly into the abdomen (intraperitoneal) works better than into a vein (intravenous) when combined with the drug bevacizumab for people with advanced ovarian, fallopian tube, or primary peritoneal cancer. Over 1,500 participants to…
Matched conditions: FALLOPIAN TUBE CLEAR CELL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 04:28 UTC